Lobster Trap Co., Inc. in Bourne, Massachusetts receives FDA inspection

Lobster Trap Co., Inc. in Bourne, Massachusetts receives FDA inspection
0Comments

Lobster Trap Co., Inc. in Bourne, Massachusetts was inspected by the Food and Drug Administration (FDA) on July 11 for foodborne biological hazards and received three citations, according to data posted on the FDA’s official website.

The FDA website indicates that the citations were delivered to the company as follows:

‘Your HACCP plan does not list the food safety hazards that are reasonably likely to occur.’

‘You did not review your critical control point monitoring records within one week after the records were made.’

‘You are not monitoring the sanitation conditions and practices with sufficient frequency to assure conformance with Current Good Manufacturing Practices including prevention of cross-contamination from insanitary objects, maintenance of hand washing, hand sanitizing, and toilet facilities and protection of food, food packaging material, and food contact surfaces from adulteration.’

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency that is primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.



Related

Dr. Mehmet Oz CMS Administrator

Gloucester Medicaid expenditures for ambulance and transport services rise to $1.56 million in 2024

Medicaid expenditures for Ambulance and Other Transport Services and Supplies in Gloucester grew by 14.8% in 2024, indicating shifts in use and reimbursement rates.

Dr. Mehmet Oz CMS Administrator

Revere Medicaid payments for Temporary National Codes (Non-Medicare) rise to $5.7 million in 2024

Medicaid expenditures for Temporary National Codes (Non-Medicare) services in Revere grew by 20.7% in 2024, pointing to shifts in how and where these services were used and reimbursed.

Dr. Mehmet Oz CMS Administrator

Peabody Medicaid claims for Temporary National Codes rise to $9,428,110 in 2024

Peabody providers billed $9,428,110 to Medicaid for Temporary National Codes (Non-Medicare) services in 2024, reflecting a 29.3% growth from the prior year.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from North Boston News.